SFPIA
CHTP

Stevens First Principles Investment Advisors’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Stevens First Principles Investment Advisors’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,000
Closed -$13K – 234
2013
Q4 		$13K Buy
3,000
+1,000
+50% +$3.38K 0.01% 173
2013
Q3 		$6K Buy
+2,000
New +$5.74K ﹤0.01% 193

Other funds holding CHTP

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GH
Green Holdings Hamilton, Bermuda $9.16M AUM 15.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stevens First Principles Investment Advisors's CHTP Position: Q1 2014 in Review

Stevens First Principles Investment Advisors sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q1 2014, closing a stake of 3,000 shares — an estimated $13K sold.

Stevens First Principles Investment Advisors first reported a position in CHTP in Q3 2013 and held it in 2 quarters. The position peaked at $13K in Q4 2013. 85 funds tracked by Wall St. Rank hold CHTP as of Q1 2014.

  • Stevens First Principles Investment Advisors reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q1 2014 after selling out during the quarter.
  • Stevens First Principles Investment Advisors sold 3,000 CHELSEA THERAPEUTICS INT'L LTD shares in Q1 2014, an estimated $13K.
  • Stevens First Principles Investment Advisors first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q3 2013 and held it in 2 quarters.
  • Stevens First Principles Investment Advisors's CHELSEA THERAPEUTICS INT'L LTD position peaked at $13K in Q4 2013.
  • 85 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q1 2014.

Based on Stevens First Principles Investment Advisors's 13F filing for Q1 2014, filed 15 May 2014.